The DOI matches its Crossref record; 148 of the 148 references it cites were found in a registry or an index.
NF-κβ: A Potential Target in the Management of Vascular Complications of Diabetes
Open accessAbstract
Diabetes is a metabolic disorder affecting large percentage of population worldwide. NF-κβ plays key role in pathogenesis of vascular complications of diabetes. Persistent hyperglycemia activates NF-κβ that triggers expression of various cytokines, chemokines and cell adhesion molecules. Over-expression of TNF-α, interleukins, TGF-β, Bcl2 and other pro-inflammatory proteins and pro-apoptotic genes by NF-κβ is key risk factor in vascular dysfunction. NF-κβ over-expression also triggers calcification of endothelial cells leading to endothelial dysfunction and further vascular complications. Inhibition of NF-κβ pro-inflammatory pathway is upcoming novel target for management of vascular complications of diabetes. Various natural and synthetic inhibitors of NF-κβ have been studied in management of diabetic complications. Recent preclinical and clinical studies validate NF-κβ as promising target in the management of vascular complications of diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
The Pathobiology of Diabetic Complications
Brownlee, M. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1615 · Cited by 5,339
Global prevalence and major risk factors of diabetic retinopathy
Yau, J. W. Y., Rogers, S. L., Kawasaki, R., Lamoureux, E. L., Kowalski, J. W., Bek, T., Chen, S.-J., Dekker, J. M., Fletcher, A., Grauslund, J., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1909 · Cited by 4,985
The Nuclear Factor NF- B Pathway in Inflammation
Lawrence, T. (2009) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001651 · Cited by 4,898
Phosphorylation meets ubiquitination: the control of NF-κB activity
Karin, M., & Ben-Neriah, Y. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.621 · Cited by 4,766 · cited 1×
“In canonical pathway when signal is transduced, NEMO-containing IKK complexes are activated and induce phosphorylation of IKK complex via ubiquitination leading to release of NF-κβ dimers (Karin and Ben-Neriah, 2000).”
BackgroundNF-κB regulation in the immune system
Li, Q., & Verma, I. M. (2002) · Nature Reviews Immunology · doi:10.1038/nri910 · Cited by 4,007
Hayden, M. S., & Ghosh, S. (2004) · Genes & Development · doi:10.1101/gad.1228704 · Cited by 3,842
Missing Pieces in the NF-κB Puzzle
Ghosh, S., & Karin, M. (2002) · Cell · doi:10.1016/s0092-8674(02)00703-1 · Cited by 3,638 · cited 2×
“These transcription proteins possess dimerization domain to which DNA binds; Rel homology domain (RHD) at N-terminal facilitates site for dimerization through which they forms homo or hetero–dimers (Ghosh and Karin, 2002; Hayden and Ghosh, 2011).”
BackgroundDanaei, G., Finucane, M. M., Lu, Y., Singh, G. M., Cowan, M. J., Paciorek, C. J., Lin, J. K., Farzadfar, F., Khang, Y.-H., Stevens, G. A., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60679-x · Cited by 3,568
Integrating cell-signalling pathways with NF-κB and IKK function
Perkins, N. D. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2083 · Cited by 2,350
Introduction to NF-κB: players, pathways, perspectives
Gilmore, T. D. (2006) · Oncogene · doi:10.1038/sj.onc.1209954 · Cited by 2,222
Esposito, K., Nappo, F., Marfella, R., Giugliano, G., Giugliano, F., Ciotola, M., Quagliaro, L., Ceriello, A., & Giugliano, D. (2002) · Circulation · doi:10.1161/01.cir.0000034509.14906.ae · Cited by 1,961 · cited 1×
“The increased ROS activates NF-κβ canonically and non-canonically that triggers NF-κβ dependent gene expression and production of pro-inflammatory cytokines IL-6, IL-10 and TNF-α in human heart (Esposito et al., 2002; Jones et al., 2003).”
BackgroundNF-κB, Inflammation, and Metabolic Disease
Baker, R. G., Hayden, M. S., & Ghosh, S. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2010.12.008 · Cited by 1,952
Boulton, A. J. M., Vinik, A. I., Arezzo, J. C., Bril, V., Feldman, E. L., Freeman, R., Malik, R. A., Maser, R. E., Sosenko, J. M., & Ziegler, D. (2005) · Diabetes Care · doi:10.2337/diacare.28.4.956 · Cited by 1,859
1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system
Li, Y. C., Kong, J., Wei, M., Chen, Z.-F., Liu, S. Q., & Cao, L.-P. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215219 · Cited by 1,625
Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss
Lee, R., Wong, T. Y., & Sabanayagam, C. (2015) · Eye and Vision · doi:10.1186/s40662-015-0026-2 · Cited by 1,569
Advanced Glycation End Products and Diabetic Complications
Singh, V. P., Bali, A., Singh, N., & Jaggi, A. S. (2014) · The Korean Journal of Physiology & Pharmacology · doi:10.4196/kjpp.2014.18.1.1 · Cited by 1,518
Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I
Paneni, F., Beckman, J. A., Creager, M. A., & Cosentino, F. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht149 · Cited by 1,401
Dissecting molecular cross-talk between Nrf2 and NF-κB response pathways
Wardyn, J. D., Ponsford, A. H., & Sanderson, C. M. (2015) · Biochemical Society Transactions · doi:10.1042/bst20150014 · Cited by 1,200 · cited 1×
“The role of NF-κβ and erythroid 2-related factor 2 (Nrf2) has been explored in diabetic neuropathy (Li et al., 2008; Ganesh Yerra et al., 2013; Wardyn et al., 2015).”
BackgroundPrevalence of Diabetic Retinopathy in the United States, 2005-2008
Zhang, X., Saaddine, J. B., Chou, C.-F., Cotch, M. F., Cheng, Y. J., Geiss, L. S., Gregg, E. W., Albright, A. L., Klein, B. E. K., & Klein, R. (2010) · JAMA · doi:10.1001/jama.2010.1111 · Cited by 1,196
Inflammation and insulin resistance
de Luca, C., & Olefsky, J. M. (2008) · FEBS Letters · doi:10.1016/j.febslet.2007.11.057 · Cited by 1,161
Hayden, M. S., & Ghosh, S. (2011) · Cell Research · doi:10.1038/cr.2011.13 · Cited by 1,117
Inflammation in diabetic retinopathy
Tang, J., & Kern, T. S. (2011) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2011.05.002 · Cited by 1,116
Molecular Basis of NF-κB Signaling
Napetschnig, J., & Wu, H. (2013) · Annual Review of Biophysics · doi:10.1146/annurev-biophys-083012-130338 · Cited by 933
Diabetic Cardiomyopathy: Evidence, Mechanisms, and Therapeutic Implications
Fang, Z. Y., Prins, J. B., & Marwick, T. H. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0012 · Cited by 912
Lander, H. M., Tauras, J. M., Ogiste, J. S., Hori, O., Moss, R. A., & Schmidt, A. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.28.17810 · Cited by 813
Hammes, H.-P., Du, X., Edelstein, D., Taguchi, T., Matsumura, T., Ju, Q., Lin, J., Bierhaus, A., Nawroth, P., Hannak, D., et al. (2003) · Nature Medicine · doi:10.1038/nm834 · Cited by 785
Regulation of matrix metalloproteinase gene expression
Yan, C., & Boyd, D. D. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.20948 · Cited by 754
Antonetti, D. A., Barber, A. J., Bronson, S. K., Freeman, W. M., Gardner, T. W., Jefferson, L. S., Kester, M., Kimball, S. R., Krady, J. K., LaNoue, K. F., et al. (2006) · Diabetes · doi:10.2337/db05-1635 · Cited by 746
Activation of Nrf2-antioxidant signaling attenuates NFκB-inflammatory response and elicits apoptosis
Li, W., Khor, T. O., Xu, C., Shen, G., Jeong, W.-S., Yu, S., & Kong, A.-N. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.07.017 · Cited by 738
TGF-β/Smad signaling in renal fibrosis
Meng, X.-M., Tang, P. M.-K., Li, J., & Lan, H. Y. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00082 · Cited by 666
Sanz, A. B., Sanchez-Niño, M. D., Ramos, A. M., Moreno, J. A., Santamaria, B., Ruiz-Ortega, M., Egido, J., & Ortiz, A. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010020218 · Cited by 567
Leukocyte-Mediated Endothelial Cell Injury and Death in the Diabetic Retina
Joussen, A. M., Murata, T., Tsujikawa, A., Kirchhof, B., Bursell, S.-E., & Adamis, A. P. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63952-1 · Cited by 567
A single NFκB system for both canonical and non-canonical signaling
Shih, V. F.-S., Tsui, R., Caldwell, A., & Hoffmann, A. (2011) · Cell Research · doi:10.1038/cr.2010.161 · Cited by 499
Mechanism of diabetic neuropathy: Where are we now and where to go?
Yagihashi, S., Mizukami, H., & Sugimoto, K. (2011) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2010.00070.x · Cited by 488
The Polyol Pathway as a Mechanism for Diabetic Retinopathy: Attractive, Elusive, and Resilient
Lorenzi, M. (2007) · Journal of Diabetes Research · doi:10.1155/2007/61038 · Cited by 472
Diabetic cardiomyopathy: pathophysiology and clinical features
Miki, T., Yuda, S., Kouzu, H., & Miura, T. (2013) · Heart Failure Reviews · doi:10.1007/s10741-012-9313-3 · Cited by 460
Spector, K. S. (1998) · Clinical Cardiology · doi:10.1002/clc.4960211205 · Cited by 443
Classification of diabetic retinopathy and diabetic macular edema
Wu, L. (2013) · World Journal of Diabetes · doi:10.4239/wjd.v4.i6.290 · Cited by 439
Modular Activation of Nuclear Factor-κB Transcriptional Programs in Human Diabetic Nephropathy
Schmid, H., Boucherot, A., Yasuda, Y., Henger, A., Brunner, B., Eichinger, F., Nitsche, A., Kiss, E., Bleich, M., Gröne, H.-J., et al. (2006) · Diabetes · doi:10.2337/db06-0477 · Cited by 419
Ganesh Yerra, V., Negi, G., Sharma, S. S., & Kumar, A. (2013) · Redox Biology · doi:10.1016/j.redox.2013.07.005 · Cited by 412
NLRP3 Gene Silencing Ameliorates Diabetic Cardiomyopathy in a Type 2 Diabetes Rat Model
Luo, B., Li, B., Wang, W., Liu, X., Xia, Y., Zhang, C., Zhang, M., Zhang, Y., & An, F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104771 · Cited by 408
The Transcription Factor NF-κB and the Regulation of Vascular Cell Function
de Martin, R., Hoeth, M., Hofer-Warbinek, R., & Schmid, J. A. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.11.e83 · Cited by 408
Diabetes mellitus and its complications in India
Unnikrishnan, R., Anjana, R. M., & Mohan, V. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.53 · Cited by 393
The NF-κB activation pathways, emerging molecular targets for cancer prevention and therapy
Lin, Y., Bai, L., Chen, W., & Xu, S. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220903431069 · Cited by 384
Glucose and diabetic vascular disease 1
Ruderman, N. B., Williamson, J. R., & Brownlee, M. (1992) · The FASEB Journal · doi:10.1096/fasebj.6.11.1644256 · Cited by 375
Sandireddy, R., Yerra, V. G., Areti, A., Komirishetty, P., & Kumar, A. (2014) · International Journal of Endocrinology · doi:10.1155/2014/674987 · Cited by 364
Oxidative Stress and Programmed Cell Death in Diabetic Neuropathy
VINCENT, A. M., BROWNLEE, M., & RUSSELL, J. W. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb02108.x · Cited by 361
Tobon-Velasco, J., Cuevas, E., & Torres-Ramos, M. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527313666140806144831 · Cited by 355
The Role of AGE/RAGE Signaling in Diabetes-Mediated Vascular Calcification
Kay, A. M., Simpson, C. L., & Stewart, J. A. (2016) · Journal of Diabetes Research · doi:10.1155/2016/6809703 · Cited by 346
The role of oxidative stress and NF‐κB activation in late diabetic complications
Mohamed, A. K., Bierhaus, A., Schiekofer, S., Tritschler, H., Ziegler, R., & Nawroth, P. P. (1999) · BioFactors · doi:10.1002/biof.5520100211 · Cited by 339
Effects of curcumin on retinal oxidative stress and inflammation in diabetes
Kowluru, R. A., & Kanwar, M. (2007) · Nutrition & Metabolism · doi:10.1186/1743-7075-4-8 · Cited by 327
Negi, G., Kumar, A., & Sharma, S. S. (2011) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2010.00821.x · Cited by 314
Signaling Molecules of the NF-κB Pathway Shuttle Constitutively between Cytoplasm and Nucleus
Birbach, A., Gold, P., Binder, B. R., Hofer, E., de Martin, R., & Schmid, J. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112475200 · Cited by 299
Targeting Nuclear Factor-Kappa B to Overcome Resistance to Chemotherapy
Godwin, P., Baird, A. M., Heavey, S., Barr, M. P., O’Byrne, K. J., & Gately, K. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00120 · Cited by 296
Role of NF-κB in the pathogenesis of diabetes and its associated complications
Patel, S., & Santani, D. (2009) · Pharmacological Reports · doi:10.1016/s1734-1140(09)70111-2 · Cited by 289
Kowluru, R. A., Koppolu, P., Chakrabarti, S., & Chen, S. (2003) · Free Radical Research · doi:10.1080/10715760310001604189 · Cited by 289
The Pathogenesis of Chronic Renal Failure in Diabetic Nephropathy
Bohle, A., Wehrmann, M., Bogenschütz, O., Batz, C., Müller, G. A., & Müller, G. A. (1991) · Pathology - Research and Practice · doi:10.1016/s0344-0338(11)80780-6 · Cited by 285
Safi, S. Z., Qvist, R., Kumar, S., Batumalaie, K., & Ismail, I. S. B. (2014) · BioMed Research International · doi:10.1155/2014/801269 · Cited by 257
The use of animal models in the study of diabetes mellitus.
Chatzigeorgiou, A., Halapas, A., Kalafatakis, K., & Kamper, E. F. (2009) · PubMed · Cited by 252
Inflammatory cytokines in vitreous fluid and serum of patients with diabetic vitreoretinopathy
Yuuki, T., Kanda, T., Kimura, Y., Kotajima, N., Tamura, J., Kobayashi, I., & Kishi, S. (2001) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(01)00155-6 · Cited by 248
Expanding role of ubiquitination in NF-κB signaling
Liu, S., & Chen, Z. J. (2011) · Cell Research · doi:10.1038/cr.2010.170 · Cited by 241
Epidemiology of Diabetic Nephropathy
Reutens, A. T., & Atkins, R. C. (2011) · Contributions to Nephrology · doi:10.1159/000324934 · Cited by 235
Diabetic nephropathy: the role of inflammation in fibroblast activation and kidney fibrosis
Kanasaki, K., Taduri, G., & Koya, D. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00007 · Cited by 227
Okamoto, K., Martin, D. P., Schmelzer, J. D., Mitsui, Y., & Low, P. A. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7677 · Cited by 226
Curcumin attenuates thermal hyperalgesia in a diabetic mouse model of neuropathic pain
Sharma, S., Kulkarni, S. K., Agrewala, J. N., & Chopra, K. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.03.006 · Cited by 219
Soetikno, V., Sari, F. R., Veeraveedu, P. T., Thandavarayan, R. A., Harima, M., Sukumaran, V., Lakshmanan, A. P., Suzuki, K., Kawachi, H., & Watanabe, K. (2011) · Nutrition & Metabolism · doi:10.1186/1743-7075-8-35 · Cited by 219
Khajehdehi, P., Pakfetrat, M., Javidnia, K., Azad, F., Malekmakan, L., Nasab, M. H., & Dehghanzadeh, G. (2011) · Scandinavian Journal of Urology and Nephrology · doi:10.3109/00365599.2011.585622 · Cited by 212
Singh, J., & Kakkar, P. (2009) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2009.02.038 · Cited by 210
Pregabalin in Neuropathic Pain: Evidences and Possible Mechanisms
Verma, V., Singh, N., & Jaggi, A. (2014) · Current Neuropharmacology · doi:10.2174/1570159x1201140117162802 · Cited by 210
Ohga, S., Shikata, K., Yozai, K., Okada, S., Ogawa, D., Usui, H., Wada, J., Shikata, Y., & Makino, H. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00288.2005 · Cited by 203
Prevalence of type 2 diabetes and its complications in India and economic costs to the nation
Pradeepa, R., & Mohan, V (2017) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2017.40 · Cited by 200
Epigenetic mechanisms in diabetic vascular complications
Reddy, M. A., & Natarajan, R. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr024 · Cited by 199
Bell, D. S. H. (2003) · Diabetes Care · doi:10.2337/diacare.26.10.2949 · Cited by 198
Molecular mechanisms of diabetic vascular complications
Kitada, M., Zhang, Z., Mima, A., & King, G. L. (2010) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2010.00018.x · Cited by 193
Mitogen-activated protein kinases as glucose transducers for diabetic complications
Tomlinson, D. R. (1999) · Diabetologia · doi:10.1007/s001250051439 · Cited by 193
Nerve Growth Factor and Diabetic Neuropathy
Pittenger, G., & Vinik, A. (2003) · Journal of Diabetes Research · doi:10.1155/edr.2003.271 · Cited by 188
Yagihashi, S., Yamagishi, S.-I., & Wada, R. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.01.054 · Cited by 188
Matrix metalloproteinases in diabetic retinopathy: potential role of MMP-9
Kowluru, R. A., Zhong, Q., & Santos, J. M. (2012) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2012.681043 · Cited by 187
Pal, P. B., Sinha, K., & Sil, P. C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107220 · Cited by 185
Kumar, A., & Sharma, S. S. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.03.014 · Cited by 183
Bellas, R. E., Lee, J. S., & Sonenshein, G. E. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118313 · Cited by 183
Negi, G., Kumar, A., & S. Sharma, S. (2011) · Current Neurovascular Research · doi:10.2174/156720211798120972 · Cited by 183
Zhang, Z., Yuan, W., Sun, L., Szeto, F. L., Wong, K. E., Li, X., Kong, J., & Li, Y. C. (2007) · Kidney International · doi:10.1038/sj.ki.5002296 · Cited by 173
Microvascular complications of diabetes
He, Z., & King, G. L. (2004) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2003.12.003 · Cited by 169
Potential Role of Nuclear FactorκB in Diabetic Cardiomyopathy
Lorenzo, O., Picatoste, B., Ares-Carrasco, S., Ramírez, E., Egido, J., & Tuñón, J. (2011) · Mediators of Inflammation · doi:10.1155/2011/652097 · Cited by 168
Role of Interleukin-1β in the Development of Retinopathy in Rats: Effect of Antioxidants
Kowluru, R. A., & Odenbach, S. (2004) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.04-0633 · Cited by 164
Celastrol, an NF-κB Inhibitor, Improves Insulin Resistance and Attenuates Renal Injury in db/db Mice
Kim, J. E., Lee, M., Nam, D. H., Song, H. K., Kang, Y. S., Lee, J. E., Kim, H. W., Joo, J., Hyun, Y. Y., Han, S. Y., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062068 · Cited by 162
The Prevalence of Diabetic Cardiomyopathy: A Population-Based Study in Olmsted County, Minnesota
Dandamudi, S., Slusser, J., Mahoney, D. W., Redfield, M. M., Rodeheffer, R. J., & Chen, H. H. (2014) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2014.02.007 · Cited by 161
Involvement of extracellular signal-regulated kinase and p38 in human diabetic nephropathy
Sakai, N., Wada, T., Furuichi, K., Iwata, Y., Yoshimoto, K., Kitagawa, K., Kokubo, S., Kobayashi, M., Hara, A., Yamahana, J., et al. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2004.08.039 · Cited by 152
Reduced cardiac hypertrophy in toll-like receptor 4-deficient mice following pressure overload
HA, T., LI, Y., HUA, F., MA, J., Gao, X. J., Kelley, J., Zhao, A. T., Haddad, G. E., WILLIAMS, D., & WILLIAMBROWDER, I. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.05.025 · Cited by 152
Lee, F., Cao, Z., Long, D. M., Panagiotopoulos, S., Jerums, G., Cooper, M. E., & Forbes, J. M. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000135055.61833.a8 · Cited by 150
NF-κB as an Integrator of Diverse Signaling Pathways: The Heart of Myocardial Signaling?
Jones, W. K., Brown, M. A., Ren, X., He, S., & McGuinness, M. (2003) · Cardiovascular Toxicology · doi:10.1385/ct:3:3:229 · Cited by 147
Alpha-Lipoic Acid and Diabetic Neuropathy
Vallianou, N. G., Evangelopoulos, A. A., & Koutalas, P. (2009) · The Review of Diabetic Studies · doi:10.1900/rds.2009.6.230 · Cited by 145
Joshi, R. P., Negi, G., Kumar, A., Pawar, Y. B., Munjal, B., Bansal, A. K., & Sharma, S. S. (2013) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2013.01.001 · Cited by 144
Sugimoto, K., Nishizawa, Y., Horiuchi, S., & Yagihashi, S. (1997) · Diabetologia · doi:10.1007/s001250050839 · Cited by 142
NF-κB Inhibitors for the Treatment of Inflammatory Diseases and Cancer
Calzado, M. A., Bacher, S., & Schmitz, M. L. (2007) · Current Medicinal Chemistry · doi:10.2174/092986707779941113 · Cited by 142
HMG-CoA reductase inhibitor ameliorates diabetic nephropathy by its pleiotropic effects in rats
Usui, H. K. (2003) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/18.2.265 · Cited by 139
TGF-β Signaling via TAK1 Pathway: Role in Kidney Fibrosis
Choi, M. E., Ding, Y., & Kim, S. I. (2012) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2012.04.003 · Cited by 138
Effects of p38 MAPK Inhibition on Early Stages of Diabetic Retinopathy and Sensory Nerve Function
Du, Y., Tang, J., Li, G., Berti-Mattera, L., Lee, C. A., Bartkowski, D., Gale, D., Monahan, J., Niesman, M. R., Alton, G., et al. (2010) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.09-3674 · Cited by 136
Structural studies of NF-κB signaling
Zheng, C., Yin, Q., & Wu, H. (2011) · Cell Research · doi:10.1038/cr.2010.171 · Cited by 134
Retinal fibrosis in diabetic retinopathy
Roy, S., Amin, S., & Roy, S. (2015) · Experimental Eye Research · doi:10.1016/j.exer.2015.04.004 · Cited by 129
Yeh, P., Huang, H.-W., Yang, C., Yang, W.-S., & Yang, C.-H. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146438 · Cited by 127
Dynamic DNA methylation of matrix metalloproteinase-9 in the development of diabetic retinopathy
Kowluru, R. A., Shan, Y., & Mishra, M. (2016) · Laboratory Investigation · doi:10.1038/labinvest.2016.78 · Cited by 126
Kim, H., Han, T.-H., & Lee, S.-G. (2008) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2008.12.011 · Cited by 115
Muthuraman, A., & Singh, N. (2011) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-11-24 · Cited by 114
Pan, Y., Zhang, X., Wang, Y., Cai, L., Ren, L., Tang, L., Wang, J., Zhao, Y., Wang, Y., Liu, Q., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079084 · Cited by 113
Riley, C. L., Boutz, D., Bean, C., Kohno, S., Tioli, G., Genova, M. L., Scorrano, L., & L Mills, E. (2020) · The FASEB Journal · doi:10.1096/fj.1530-6860 · Cited by 112
Ilatovskaya, D. V., Levchenko, V., Lowing, A., Shuyskiy, L. S., Palygin, O., & Staruschenko, A. (2015) · Scientific Reports · doi:10.1038/srep17637 · Cited by 110
1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system
Li, Y. C., Kong, J., Wei, M., Chen, Z., Liu, S. Q., & Cao, L.-P. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200215219 · Cited by 105
Zhu, S., Liu, B., Hao, M., Fan, Y., Cheng, Q., Teng, P., Zhou, X., Hu, L., Liu, W., Yuan, Z., et al. (2017) · Inflammation · doi:10.1007/s10753-017-0571-z · Cited by 99
KAWANO, S., KUBOTA, T., Monden, Y., Kawamura, N., Tsutsui, H., Takeshita, A., & Sunagawa, K. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.04.030 · Cited by 96
Wang, Y., Schmeichel, A. M., Iida, H., Schmelzer, J. D., & Low, P. A. (2006) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2006.03.011 · Cited by 95
(2011) · Environmental Health Perspectives · doi:10.1289/image.ehp.v119.i03 · Cited by 94
Pathogenesis of Painful Diabetic Neuropathy
Aslam, A., Singh, J., & Rajbhandari, S. M. (2014) · Pain Research and Treatment · doi:10.1155/2014/412041 · Cited by 90
Curcumin Attenuates Diabetic Neuropathic Pain by Downregulating TNF-α in a Rat Model
Li, Y., Zhang, Y., Liu, D.-B., Liu, H., Hou, W., & Dong, Y. (2013) · International Journal of Medical Sciences · doi:10.7150/ijms.5224 · Cited by 88
Yu, H., Zhen, J., Yang, Y., Gu, J., Sui-sheng, W., & Liu, Q. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12739 · Cited by 88
Haslbeck, K.-M., Schleicher, E., Bierhaus, A., Nawroth, P., Haslbeck, M., Neundörfer, B., & Heuss, D. (2005) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2005-865600 · Cited by 86
Therapeutic strategies of diabetic nephropathy: recent progress and future perspectives
Lv, M., Chen, Z., Hu, G., & Li, Q. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.10.007 · Cited by 85
Yamagishi, S., Ogasawara, S., Mizukami, H., Yajima, N., Wada, R., Sugawara, A., & Yagihashi, S. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05050.x · Cited by 84
Liu, W., Zhang, X., Liu, P., Shen, X., Lan, T., Li, W., Jiang, Q. L., Xie, X., & Huang, H. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.04.033 · Cited by 82
An Update on the Use of Animal Models in Diabetic Nephropathy Research
Betz, B. B., & Conway, B. R. (2016) · Current Diabetes Reports · doi:10.1007/s11892-015-0706-2 · Cited by 82
Yin, Y., Chen, F., Wang, W., Wang, H., & Zhang, X. (2017) · PubMed Central · Cited by 82
Xu, F., Wang, Y., Cui, W., Yuan, H., Sun, J., Wu, M., Guo, Q., Kong, L., Wu, H., & Miao, L. (2014) · International Journal of Endocrinology · doi:10.1155/2014/289327 · Cited by 79
Role of Angiotensin II in the Development of Nephropathy and Podocytopathy of Diabetes
Campbell, K. N., Raij, L. R., & Mundel, P. H. (2011) · Current Diabetes Reviews · doi:10.2174/157339911794273973 · Cited by 76
Lian, F., Wu, L., Tian, J., Jin, M., Zhou, S., Zhao, M., Wei, L., Zheng, Y., Wang, Y., Zhang, M., et al. (2015) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2015.01.048 · Cited by 74
Improvement of inflammatory responses associated with NF-κB pathway in kidneys from diabetic rats
Chen, L., Zhang, J., Zhang, Y., Wang, Y., & Wang, B. (2008) · Inflammation Research · doi:10.1007/s00011-006-6190-z · Cited by 70
Mohammadshahi, M., Haidari, F., & Soufi, F. G. (2013) · Cardiology Journal · doi:10.5603/cj.a2013.0051 · Cited by 68
Insulin sensitizing activity of ethyl acetate fraction of Acorus calamus L. in vitro and in vivo
Wu, H., Zhu, D., Zhou, C., et al. (2009) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2009.03.004 · Cited by 67
Li, Y., Xu, X.-B., Chen, X., Wei, G., He, B., & Wang, J.-D. (2012) · Human Reproduction · doi:10.1093/humrep/des110 · Cited by 55
Jeong, I., Oh, D. H., Park, S.-J., Kang, J.-H., Kim, S., Lee, M., Kim, M.-J., Hwang, Y.-C., Ahn, K. J., Chung, H.-Y., et al. (2011) · Experimental & Molecular Medicine · doi:10.3858/emm.2011.43.12.079 · Cited by 52
Diabetic neuropathy: mechanisms and future treatment options
Thomas, P. K. (1999) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.67.3.277 · Cited by 52
Nerve growth factor in diabetic retinopathy: beyond neurons
Mysona, B. A., Shanab, A. Y., Elshaer, S. L., & El‐Remessy, A. B. (2014) · Expert Review of Ophthalmology · doi:10.1586/17469899.2014.903157 · Cited by 50
Peroxisome proliferator-activated receptor agonists modulate neuropathic pain: a link to chemokines?
Freitag, C. M., & Miller, R. J. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00238 · Cited by 46
Xing, L. V., Lv, G., Guo-Ying, D. A. I., Sun, H., & Xu, H. (2016) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(16)30101-7 · Cited by 44
Ma, Q., Chen, D., Sun, H., Yan, N., Xu, Y., & Pan, C. (2015) · Journal of Diabetes Research · doi:10.1155/2015/231570 · Cited by 42
Zamboni, M., Francesco, V. D., Garbin, U., Pasini, A., Mazzali, G., Stranieri, C., Zoico, E., Fantin, F., Bosello, O., & Cominacini, L. (2007) · International Journal of Obesity · doi:10.1038/sj.ijo.0803563 · Cited by 41
Kochumon, S., Al-Roub, A., Al-Ghanim, M., Al‐Mass, A., Behbehani, K., & Ahmad, R. (2015) · Journal of Inflammation · doi:10.1186/s12950-015-0077-0 · Cited by 33
Borgohain, M. P., Lahkar, M., Ahmed, S., Chowdhury, L., Kumar, S., Pant, R., & Choubey, A. (2016) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12718 · Cited by 31
Role of NF- B in the pathogenesis of diabetes and its associated complications
Patel, S., & Santani, D. D. (2009) · Cited by 30
NF-kB Expression in IgA Nephropathy Outcome
Silva, G. E. B., Costa, R. S., Ravinal, R. C., Ramalho, L. N. Z., dos Reis, M. A., Coimbra, T. M., & Dantas, M. (2011) · Disease Markers · doi:10.1155/2011/940827 · Cited by 29
Effect of Salvia miltiorrhiza on retinopathy
Zhang, L., Dai, S.-Z., Nie, X.-D., Zhu, L., Xing, F., & Wang, L. (2013) · Asian Pacific Journal of Tropical Medicine · doi:10.1016/s1995-7645(13)60011-5 · Cited by 28
Application of a Novel Curcumin Analog in the Management of Diabetic Cardiomyopathy
Ren, J. T., & Sowers, J. R. (2014) · Diabetes · doi:10.2337/db14-0863 · Cited by 28
A New Road for Treating the Vascular Complications of Diabetes: So Let's Step on the Gas
Evans, J. L., & Goldfine, I. D. (2016) · Diabetes · doi:10.2337/dbi15-0029 · Cited by 26
Jiang, N., Chen, X.-L., Yang, H., & Ma, Y.-R. (2015) · PubMed Central · doi:10.3980/j.issn.2222-3959.2015.03.03 · Cited by 24
Immunoinflammation in Diabetic Nephropathy: Molecular Mechanisms and Therapeutic Options
López-Parra, V., Mallavia, B., Egido, J., & Gómez‐Guerrero, C. (2012) · InTech eBooks · doi:10.5772/34541 · Cited by 20
Zhang, K., Ferreyra, H. A., Grob, S., Bedell, M., & Zhang, J. J. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4557-0737-9.00046-1 · Cited by 16
Effects of Curcumin in Experimental Diabetic Nephropathy
Prabhakar, S. S. (2016) · Journal of Investigative Medicine · doi:10.1136/jim-2016-000272 · Cited by 9
Cited by
Advanced Glycation End Products and Diabetes Mellitus: Mechanisms and Perspectives
Khalid, M., Petroianu, G., & Adem, A. (2022) · Biomolecules · doi:10.3390/biom12040542 · Cited by 879
Yuan, T., Yang, T., Chen, H., Fu, D., Hu, Y., Wang, J., Yuan, Q., Yu, H., Xu, W., & Xie, X. (2019) · Redox Biology · doi:10.1016/j.redox.2018.09.025 · Cited by 743
Sun, H.-J., Wu, Z.-Y., Nie, X.-W., & Bian, J.-S. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01568 · Cited by 554
Pathogenic Pathways and Therapeutic Approaches Targeting Inflammation in Diabetic Nephropathy
Rayego-Mateos, S., Morgado-Pascual, J. L., Opazo-Ríos, L., Guerrero-Hue, M., García-Caballero, C., Vázquez-Carballo, C., Mas, S., Sanz, A. B., Herencia, C., Mezzano, S., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21113798 · Cited by 334
Scioli, M. G., Storti, G., D’Amico, F., Rodríguez Guzmán, R., Centofanti, F., Doldo, E., Céspedes Miranda, E. M., & Orlandi, A. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9061995 · Cited by 281
Metadata
- Authors
- Suryavanshi, S. V., & Kulkarni, Y. A.
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2017-11-07
- Volume
- 8
- Pages
- 798-798
- ISSN
- 1663-9812 (ISSN-L)
- OpenAlex
- W2767589056
- Cited by
- 348
- References
- 148
- FWCI
- 6.14
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.